Lehigh Valley Cancer Institute
In a moment of hopelessness, Prima found HOPE.
In the battle against cancer, you want every available weapon on your side. To help provide you with the most advanced cancer care, Lehigh Valley Cancer Institute is a member of the Memorial Sloan Kettering (MSK) Cancer Alliance so we take your cancer fight to a new level. Cancer Institute patients have access to MSK clinical trials, which accelerates the data-collection process so investigational treatments can be approved faster and become available to more patients. Lehigh Valley Cancer Institute is currently participating in elite cancer trials, including:
Affiliated with the federal government’s Cancer Moonshot program to accelerate cancer research, the TAPUR study provides eligible patients with medication not yet approved by the FDA for their particular cancer type and collects data on the clinical response. Lehigh Valley Cancer Institute is one of only two TAPUR sites in Pennsylvania.
The purpose of the Strata study is to investigate the genes in a patient’s tumor, provide a report back to their doctor, and collect data about whether this information helps doctors in treating patients with approved medicines or helps study doctors to enroll subjects in clinical trials. Some cancer patients have tumors with particular mutations, which may be treated with “targeted therapy” drugs. Some may be available through prescription, or some may be available on a clinical trial. Subjects enrolled on the Strata trial will submit left-over tumor tissue to test for these mutations, and a test report will be provided to their physician at no cost to the patient.
Find out more information about these clinical research trials and additional research opportunities at Lehigh Valley Cancer Institute: